← Back to Patent Explorer
US4199569A Expired / Lapsed US ⏱️ 0.0 years remaining

Selective hydrogenation products of C-076 compounds and derivatives thereof

Assignee: Merck and Co Inc
•
Filing: 1978-07-31
•
Granted: 1980-04-22
•
Expires: 1998-07-31
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Derivatives of C-076 are described in which the C-076 molecule, as series of macrolides, has a specific unsaturation, at the 22,23-position, catalytically reduced. Further reaction of the reduced C-076 compounds are also possible. The compounds thus produced have profound anthelmintic, insecticidal, ectoparasiticidal and acaracidal activity. Compositions containing the described C-076 derivatives as the active ingredient thereof are also disclosed.

Inventors

  • 👤 John C. Chabala
  • 👤 Michael H. Fisher

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-26 18:48
CPC Classifications
C; C07; C07D; C07D493/00; C07D493/22; A; A01; A01N; A01N43/00; A01N43/90; C07H; C07H17/00; C07H17/04; C07H17/08; C12; C12P; C12P19/00; C12P19/44; C12P19/60; C12P19/62; C12P19/623

Claims Analysis

Total Claims: 21
Claim 1
Independent Claim 30 words
A compound having the formula: ##STR4## wherein R 1 is iso-propyl or sec-butyl; R 2 is methoxy, hydroxy or loweralkanoyloxy; and R 3 is hydrogen; loweralkanoyl; α-L-oleandrosyl; 4'-loweralkanoyl-α-L-oleandrosyl; 4'-(α-L-oleandrosyl)-α-L-oleandrosyl, 4"-loweralkanoyl-4'-(α-L-oleandrosyl)-α-L-oleandrosyl.
Claim 2
Dependent Claim 30 words
A compound having the formula: ##STR4## wherein R 1 is iso-propyl or sec-butyl; R 2 is methoxy, hydroxy or loweralkanoyloxy; and R 3 is hydrogen; loweralkanoyl; α-L-oleandrosyl; 4'-loweralkanoyl-α-L-oleandrosyl; 4'-(α-L-oleandrosyl)-α-L-oleandrosyl, 4"-loweralkanoyl-4'-(α-L-oleandrosyl)-α-L-oleandrosyl.
Claim 3
Dependent Claim 26 words
The compound of claim 1 wherein: R 1 is iso-propyl or sec-butyl; R 2 is methoxy or hydroxy; and R 3 is hydrogen, α-L-oleandrosyl or 4'-(α-L-oleandrosyl)-α-L-oleandrosyl.
Claim 4
Dependent Claim 10 words
The compound of claim 2 wherein R 1 is iso-propyl.
Claim 5
Dependent Claim 10 words
The compound of claim 2 wherein R 1 is sec-butyl.
Claim 6
Dependent Claim 9 words
The compound of claim 4 which is 22,23-dihydro-C-076 A1a.
Claim 7
Dependent Claim 9 words
The compound of claim 4 which is 22,23-dihydro-C-076 B1a.
Claim 8
Dependent Claim 10 words
The compound of claim 4 which is 22,23-dihydro-C-076 A1a aglycone.
Claim 9
Dependent Claim 10 words
The compound of claim 4 which is 22,23-dihydro-C-076 B1a aglycone.
Claim 10
Dependent Claim 11 words
The compound of claim 4 which is 22,23-dihydro C-076 A1a monosaccharide.
Claim 11
Dependent Claim 11 words
The compound of claim 4 which is 22,23-dihydro C-076 B1a monosaccharide.
Claim 12
Dependent Claim 14 words
The compound of claim 1 wherein the loweralkanoyl group of R 3 is acetyl.
Claim 13
Dependent Claim 10 words
The compound of claim 11 which is 4"-O-acetyl-22,23-dihydro C-076 A1a.
Claim 14
Dependent Claim 10 words
The compound of claim 11 which is 4"-O-acetyl-22,23-dihydro C-076 B1a.
Claim 15
Dependent Claim 12 words
The compound of claim 11 which is 4", 5-di-O-acetyl 22,23-dihydro C-076 B1a.
Claim 16
Dependent Claim 28 words
A method for treating for parasites which comprises treating the animal or area infected with parasites with an effective amount of one or more compounds of claim 1.
Claim 17
Dependent Claim 12 words
The method of claim 15 wherein the active compound is C-076 B1a.
Claim 18
Dependent Claim 21 words
The method of claim 15 wherein the active compound is a mixture of about 80% C-076 B1a and 20% C-076 B1b.
Claim 19
Dependent Claim 21 words
A composition for the treatment of parasitic infections which comprises an inert carrier and one or more compounds of claim 1.
Claim 20
Dependent Claim 12 words
The composition of claim 18 wherein the active compound is C-076 B1a.
Claim 21
Dependent Claim 21 words
The composition of claim 18 wherein the active compound is a mixture of about 80% C-076 B1a and 20% C-076 B1a.

References Cited (Backward Citations)

US3853842A Cited
US3950360A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1983-04-22 1983-10-22 1984-04-22 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1987-04-22 1987-10-22 1988-04-22 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1991-04-22 1991-10-22 1992-04-22 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag